See more : Ackermans & Van Haaren NV (ACKB.BR) Income Statement Analysis – Financial Results
Complete financial analysis of BactiQuant A/S (BACTIQ.CO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BactiQuant A/S, a leading company in the Industrial – Pollution & Treatment Controls industry within the Industrials sector.
- Merck & Co., Inc. (MRK.PA) Income Statement Analysis – Financial Results
- Zhejiang Kingland Pipeline and Technologies Co.,Ltd. (002443.SZ) Income Statement Analysis – Financial Results
- Abri SPAC I, Inc. (ASPAW) Income Statement Analysis – Financial Results
- CYND Co., Ltd. (4256.T) Income Statement Analysis – Financial Results
- NS Tool Co., Ltd. (6157.T) Income Statement Analysis – Financial Results
BactiQuant A/S (BACTIQ.CO)
Industry: Industrial - Pollution & Treatment Controls
Sector: Industrials
Website: https://www.mycometer.com
About BactiQuant A/S
Bactiquant A/S develops and provides technology for the mobile and online surveillance of bacterial contamination levels in water. It offers Mobile Lab, a handheld tool for pollution tracking; and an online solution to quantify the bacteria in water systems. It serves various industries in the areas of aquaculture, data centers, oil and gas, water utility, industry, and pharma. The company is based in 1999 and is based in Horsholm, Denmark.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 12.30M | 12.39M | 8.36M | 5.48M | 5.65M | 5.41M |
| Cost of Revenue | 13.06M | 25.18M | 20.31M | 2.35M | 2.46M | 3.52M |
| Gross Profit | -755.71K | -12.79M | -11.95M | 3.13M | 3.20M | 1.89M |
| Gross Profit Ratio | -6.14% | -103.23% | -142.97% | 57.18% | 56.51% | 34.98% |
| Research & Development | 0.00 | 888.26K | 727.78K | 727.78K | 0.00 | 0.00 |
| General & Administrative | 0.00 | -11.19M | -8.85M | -3.69M | -3.54M | -3.43M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | -11.19M | -8.85M | -3.69M | -3.54M | -3.43M |
| Other Expenses | 10.15M | -14.88M | -12.19M | -727.78K | 0.00 | 0.00 |
| Operating Expenses | 10.15M | -26.07M | -21.04M | -4.42M | 3.58M | 3.46M |
| Cost & Expenses | 23.21M | -26.07M | -21.04M | -2.07M | 3.58M | 3.46M |
| Interest Income | 244.28K | 192.73K | 72.79K | 7.88K | 0.00 | 0.00 |
| Interest Expense | 1.52M | 700.61K | 826.97K | 11.18K | 0.00 | 0.00 |
| Depreciation & Amortization | 1.40M | 448.47K | 144.55K | 727.78K | 42.00K | 30.00K |
| EBITDA | -10.17M | -13.04M | -12.46M | -1.29M | -345.00K | -1.57K |
| EBITDA Ratio | -82.69% | -94.92% | -147.60% | -10.06% | -6.10% | -0.03% |
| Operating Income | -10.90M | -13.68M | -12.68M | -1.29M | -387.00K | -1.57K |
| Operating Income Ratio | -88.62% | -110.40% | -151.68% | -23.48% | -6.84% | -0.03% |
| Total Other Income/Expenses | -2.20M | -507.88K | -754.18K | -3.31K | 49.00K | -1.49M |
| Income Before Tax | -13.10M | -14.18M | -13.43M | -1.29M | -338.00K | -1.49M |
| Income Before Tax Ratio | -106.51% | -114.50% | -160.70% | -23.54% | -5.98% | -27.53% |
| Income Tax Expense | 0.00 | 192.73K | 118.73K | -308.72K | -65.00K | -328.00K |
| Net Income | -13.10M | -14.18M | -13.55M | -981.71K | -273.00K | -1.16M |
| Net Income Ratio | -106.51% | -114.50% | -162.12% | -17.91% | -4.83% | -21.46% |
| EPS | -0.64 | -0.72 | -0.71 | -0.07 | -0.01 | -0.06 |
| EPS Diluted | -0.64 | -0.72 | -0.71 | -0.07 | -0.01 | -0.06 |
| Weighted Avg Shares Out | 20.60M | 19.71M | 19.03M | 14.36M | 18.45M | 18.45M |
| Weighted Avg Shares Out (Dil) | 20.60M | 19.71M | 19.03M | 14.36M | 18.45M | 18.45M |
Source: https://incomestatements.info
Category: Stock Reports